TECHNICLONE CORP/DE/
10-K, EX-27, 2000-07-31
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: TECHNICLONE CORP/DE/, 10-K, EX-23.2, 2000-07-31
Next: SILICON VALLEY RESEARCH INC, 10KSB/A, 2000-07-31



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER>1

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               APR-30-2000
<CASH>                                       4,131,000
<SECURITIES>                                         0
<RECEIVABLES>                                   90,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,917,000
<PP&E>                                       1,739,000
<DEPRECIATION>                                 869,000
<TOTAL-ASSETS>                               5,953,000
<CURRENT-LIABILITIES>                        8,585,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        91,000
<OTHER-SE>                                 (2,812,000)
<TOTAL-LIABILITY-AND-EQUITY>                 5,953,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                               14,883,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                           (14,516,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (14,516,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (14,516,000)
<EPS-BASIC>                                     (0.18)
<EPS-DILUTED>                                   (0.18)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission